Pharmacokinetics of ethionamide administered under fasting conditions or with orange juice, food, or antacids

被引:39
作者
Auclair, B
Nix, DE
Adam, RD
James, GT
Peloquin, CA
机构
[1] Univ Colorado, Natl Jewish Ctr Immunol & Resp Med, Dept Med, Denver, CO 80202 USA
[2] Univ Colorado, Sch Pharm, Denver, CO 80202 USA
[3] Univ Colorado, Sch Med, Denver, CO 80202 USA
[4] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[5] Univ Arizona, Coll Med, Tucson, AZ 85721 USA
关键词
D O I
10.1128/AAC.45.3.810-814.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study was conducted in order to (i) determine the effect of food, orange juice, or antacids on the absorption of a single oral 500-mg dose of ethionamide (ETA) in healthy volunteers, including an assessment of bioequivalence, and (ii) determine ETA population pharmacokinetic (PK) parameters. The pharmacokinetics of ETA in serum was determined for 12 healthy males and females in a randomized, four-period crossover study, Volunteers received single 500-mg doses of ETA either on an empty stomach (reference) or with food, orange juice, or antacids, Serum samples were collected for 48 h and assayed by high-performance Liquid chromatography. Data were analyzed by noncompartmental and population methods. Mean test/reference ratios and 90% confidence intervals were determined. No statistically significant differences were seen in the maximum concentration of ETA (C-max), time to maximum concentration (T-max), or area under the concentration-time curve from 0 h to infinity (AUC(0-infinity)) between the four treatments (P > 0.05 by analysis of variance). The least-squares mean ratios (with confidence intervals in parentheses) for C-max were 105% (81.2 to 135%) after orange juice, 94% (72.8 to 121%) after food, and 88% (68.4 to 114%) after antacids, The least-squares mean ratios (with confidence intervals is in parentheses) for AUG(0-infinity) were 91% (72.7 to 115%) after orange juice, 96% (76.4 to 121%) after food, and 95% (75.5 to 120%) after antacids. The mean T-max was slightly prolonged following antacid or food administration (2.3 to 2.6 h) compared to administration on an empty stomach or with juice (1.7 to 1.9 h), The median population PK parameters were as follows: K-a = 0.37 to 0.48 h(-1), V/F = 2.0 to 2.8 liters/kg, CL/F = 56.5 to 72.2 liters/h, and terminal half-life = 1.7 to 2.1 h, where K-a, is the absorption rate constant, V is the volume of distribution, and CL is clearance, The PK behavior of ETA was not significantly modified by the different conditions studied. Mean ratios for AUC ranged from 0.91 to 0.96 for the orange juice, food, and antacid treatments, indicating a minimal effect on relative bioavailability, ETA can, therefore, be administered with food if tolerance is an issue.
引用
收藏
页码:810 / 814
页数:5
相关论文
共 28 条
[1]  
Balthasar JP, 1999, AM J PHARM EDUC, V63, P194
[2]   TREATMENT OF TUBERCULOSIS AND TUBERCULOSIS INFECTION IN ADULTS AND CHILDREN [J].
BASS, JB ;
FARER, LS ;
HOPEWELL, PC ;
OBRIEN, R ;
JACOBS, RF ;
RUBEN, F ;
SNIDER, DE ;
THORNTON, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (05) :1359-1374
[3]  
BENET LZ, 1995, PHARMACOTHERAPY, V15, P433
[4]   Understanding bioequivalence testing [J].
Benet, LZ .
TRANSPLANTATION PROCEEDINGS, 1999, 31 (3A) :7S-9S
[5]  
BIEDER A, 1966, ANN PHARM FR, V24, P493
[6]   An approach for widening the bioequivalence acceptance limits in the case of highly variable drugs [J].
Boddy, AW ;
Snikeris, FC ;
Kringle, RO ;
Wei, GCG ;
Oppermann, JA ;
Midha, KK .
PHARMACEUTICAL RESEARCH, 1995, 12 (12) :1865-1868
[7]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[8]  
*FOOD DRUG ADM, 1992, FED REGISTER, V57, P17997
[9]  
Gibaldi M. P., 1982, PHARMACOKINETICS
[10]  
GRONROOS JA, 1964, CURR THER RES CLIN E, V6, P105